Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study
In a previous study, we found that titrating clopidogrel maintenance doses (MDs) according to vasodilator-stimulated phosphoprotein (VASP) monitoring minimised the rate of major adverse cardiovascular and cere...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Chaoyue Hu, Xumin Zhang, Yonghua Liu, Yang Gao, Xiaohong Zhao, Hua Zhou, Yu Luo, Yaling Liu and Xiaodong Wang Tags: Research article Source Type: research
More News: Angioplasty | Atrial Fibrillation | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Plavix | Study